Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Pharmacopsychiatry
|
October 1, 1998
Cannabinoid/anandamide system and schizophrenia: is there evidence for association?
U Schneider, F M Leweke, K R Mueller-Vahl, et al.
Pharmacology, Biochemistry, and Behavior
|
June 6, 2000
Different effects of nabilone and cannabidiol on binocular depth inversion in Man
F M Leweke, U Schneider, M Radwan, et al.
Neuroreport
|
September 29, 1999
Elevated endogenous cannabinoids in schizophrenia
F M Leweke, A Giuffrida, U Wurster, et al.
Psychopharmacology
|
April 20, 1999
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man
F M Leweke, U Schneider, M Thies, et al.
Pharmacopsychiatry
|
August 27, 1999
Treatment of alcohol withdrawal syndrome with gabapentin
U Bonnet, M Banger, F M Leweke, et al.
Molecular Psychiatry
|
June 24, 2009
Global proteomic profiling reveals altered proteomic signature in schizophrenia serum
Y Levin, L Wang, E Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1996
Visual 3D illusion: a systems-theoretical approach to psychosis
U Schneider, F M Leweke, U Sternemann, et al.
Fortschritte Der Neurologie-Psychiatrie
|
January 19, 2007
[Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study]
F M Leweke, C W Gerth, D Koethe, et al.
Journal of Psychiatric Research
|
November 1, 1996
Impaired binocular depth inversion in patients with alcohol withdrawal
U Schneider, F M Leweke, W Niemcyzk, et al.
Brain, Behavior, and Immunity
|
July 12, 2023
Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis
V L Cropley, M Kittel, M Heurich, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Pharmacopsychiatry
|
October 1, 1998
Cannabinoid/anandamide system and schizophrenia: is there evidence for association?
U Schneider, F M Leweke, K R Mueller-Vahl, et al.
Pharmacology, Biochemistry, and Behavior
|
June 6, 2000
Different effects of nabilone and cannabidiol on binocular depth inversion in Man
F M Leweke, U Schneider, M Radwan, et al.
Neuroreport
|
September 29, 1999
Elevated endogenous cannabinoids in schizophrenia
F M Leweke, A Giuffrida, U Wurster, et al.
Psychopharmacology
|
April 20, 1999
Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man
F M Leweke, U Schneider, M Thies, et al.
Pharmacopsychiatry
|
August 27, 1999
Treatment of alcohol withdrawal syndrome with gabapentin
U Bonnet, M Banger, F M Leweke, et al.
Molecular Psychiatry
|
June 24, 2009
Global proteomic profiling reveals altered proteomic signature in schizophrenia serum
Y Levin, L Wang, E Schwarz, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 1, 1996
Visual 3D illusion: a systems-theoretical approach to psychosis
U Schneider, F M Leweke, U Sternemann, et al.
Fortschritte Der Neurologie-Psychiatrie
|
January 19, 2007
[Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study]
F M Leweke, C W Gerth, D Koethe, et al.
Journal of Psychiatric Research
|
November 1, 1996
Impaired binocular depth inversion in patients with alcohol withdrawal
U Schneider, F M Leweke, W Niemcyzk, et al.
Brain, Behavior, and Immunity
|
July 12, 2023
Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis
V L Cropley, M Kittel, M Heurich, et al.
Page
of 4